Arenobufagin suppresses the progression of early-stage hepatocellular carcinoma by inhibiting EpCAM-mediated tumor stemness EpCAM promotes cancer stemness and early-stage HCC progression, counteracted by arenobufagin, a potential therapeutic targeting EpCAM.

#EpCAM promotes #cancerstemness and #earlystageHCCprogression, counteracted by #arenobufagin, a potential therapeutic targeting EpCAM.

Read More: amm-journal.org/index.php/20...

#Epithelialcelladhesionmolecule @scienceopen.bsky.social